CVSA vs K
Covista Inc. vs Kellanova — AI-powered side-by-side comparison
| Metric | CVSA | K |
|---|
| AI Score |
70
|
52
|
| Price |
$137.90
|
$83.44
|
| P/E Ratio |
18.06×
|
31.74×
|
| ROE |
17.4%
|
35.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
57.3%
|
33.9%
|
| Debt / Equity |
0.63×
|
1.48×
|
| Dividend Yield |
0.0%
|
1.4%
|
| RSI (14) |
63.7
|
59.7
|
| Beta |
0.623
|
0.25
|
| Expected Upside |
+0.6%
|
—
|
AI Committee View
Current Innellis committee reasoning for CVSA versus K.
CVSA leads by 18 points.
CVSA scores 70/100 (Buy) versus K at 52/100 (Watch).
CVSA Committee View
75% agreement
4 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
K Committee View
71% agreement
7 analysts
Some positive signals exist — price structure making higher highs and higher lows — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull Case
- ROE of 31.9% shows genuine earnings power backing the valuation — Value
- Dividend yield of 2.8% pays you to wait — Value
- EPS growing 25.6% YoY — Growth
Bear Case
- Price-to-book of 7.4x prices in significant intangible value — Value
- Debt-to-equity of 1.52 adds balance-sheet risk to the value case — Value
- Revenue declining -6.4% YoY -- this is not a growth story right now — Growth